Evaluation of the Overall Quality of Life After the Neck Dissection Retro-spinal Sector (IIb), in Squamous Cell Carcinomas Clinical and Radiological N0 VADS
NCT02878655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-07-18
Summary
The nodal involvement in squamous cell carcinomas of the upper aerodigestive tract (VADS) is one of the main factors of poor prognosis, justifying the surgical management of neck dissection as a reference treatment.
Under the influence of the American Hayes Martin, it was considered until the 1960s that "over the intervention was, the greater the chance of recovery was". But has since been developed by the Argentine Osvaldo Suarez the concept of functional course, which consists of resection of lymph node tissue while retaining the main structures (muscles, nerves, vessels), as opposed to the recess radical which is reserved for the invasive metastasis.
In addition to these notions, our job is to evaluate the quality of life of patients with SCCHN, N0 clinical and radiological, enjoying a functional neck dissection including IIb sector to support the approach which would be to stop the systematic inclusion of this territory.
Conditions
- SCCHN
Sponsors & Collaborators
-
University Hospital, Caen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- France
Study Locations
More Related Trials
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
NCT02776137 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
NCT03174275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
NCT02760667 ·Status: UNKNOWN ·Phase: PHASE2
-
Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer
NCT02879214 ·Status: UNKNOWN ·Phase: PHASE2
-
Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
NCT02920216 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
NCT03837613 ·Status: UNKNOWN
-
Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer
NCT00868491 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)
NCT00357149 ·Status: COMPLETED ·Phase: PHASE2
-
Nutrition and Life QUality Patients With Head and Neck Cancers
NCT02510859 ·Status: COMPLETED ·Phase: NA
-
Neck Surgery in Treating Patients With Early-Stage Oral Cancer
NCT00571883 ·Status: UNKNOWN ·Phase: NA
-
Needs and Preferences of Patients With Head-neck Cutaneous SCC
NCT06046625 ·Status: ACTIVE_NOT_RECRUITING
-
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420 ·Status: RECRUITING ·Phase: NA
-
Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer
NCT01716195 ·Status: COMPLETED ·Phase: PHASE2
-
Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT01830556 ·Status: UNKNOWN ·Phase: PHASE2
-
Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034 ·Status: UNKNOWN ·Phase: NA
-
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
NCT05494190 ·Status: RECRUITING ·Phase: NA
-
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
NCT02784288 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01412229 ·Status: COMPLETED ·Phase: PHASE2
-
Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer
NCT03367884 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
NCT04124198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck
NCT07066878 ·Status: NOT_YET_RECRUITING
-
Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer
NCT00592059 ·Status: UNKNOWN
-
Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC
NCT04098458 ·Status: COMPLETED ·Phase: NA
-
Trial of IIb Preserving Neck Dissection
NCT00847717 ·Status: COMPLETED ·Phase: NA